These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 4554634)

  • 1. The effect of lidoflazine on the exercise capacity of normal volunteers: double-blind cycloergometric evaluations.
    Jageneau A; Brugmans J
    Arzneimittelforschung; 1972 Feb; 22(2):457-9. PubMed ID: 4554634
    [No Abstract]   [Full Text] [Related]  

  • 2. Resting, exercise and postexercise heart rate and systolic time intervals in normal men treated with lidoflazine.
    De Cock W; Schuermans V; Jageneau A; De Crée J; Brugmans J
    Arzneimittelforschung; 1973 Oct; 23(10):1450-4. PubMed ID: 4591313
    [No Abstract]   [Full Text] [Related]  

  • 3. Enhancement of coronary vasodilator action of nicotinamide adenine dinucleotide by lidoflazine.
    Afonso S; O'Brien GS; Berndt TB; Ansfield TJ; Rowe GG
    J Pharmacol Exp Ther; 1971 Dec; 179(3):573-9. PubMed ID: 4333026
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of lidoflazine on coronary circulation and myocardial metabolism in anesthetized and unanesthetized dogs.
    Takenaka T; Tachikawa S
    Arzneimittelforschung; 1970 Mar; 20(3):351-4. PubMed ID: 5467508
    [No Abstract]   [Full Text] [Related]  

  • 5. [Double-blind clinical trial of a new coronary-active drug, MD 6753].
    Dalla Volta S
    Minerva Cardioangiol; 1974 Oct; 22(10):683-90. PubMed ID: 4215049
    [No Abstract]   [Full Text] [Related]  

  • 6. [Lidoflazine in angina pectoris].
    Schlesinger P; Benchimol AB
    Arq Bras Cardiol; 1972 Oct; 25(5):397-403. PubMed ID: 4651962
    [No Abstract]   [Full Text] [Related]  

  • 7. [Changes in ECG due to lidoflazine in subjects without coronary heart disease during rest and under cycloergometric conditions].
    Lehmann HU; Scholle J; Hochrein H
    Med Welt; 1974 Sep; 25(39):1556-63. PubMed ID: 4427554
    [No Abstract]   [Full Text] [Related]  

  • 8. A double-blind clinical and ECG-evaluation of lidoflazine (R 7904) in the treatment of stabilized angina pectoris.
    Keulen UW
    Curr Med Res Opin; 1973; 1(8):469-81. PubMed ID: 4589632
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effects of LBI45, practolol and a placebo on the exercise tests of coronary patients. A double-blind study (author's transl)].
    Bloch A; Horvat L
    Schweiz Rundsch Med Prax; 1974 Jan; 63(3):62-5. PubMed ID: 4605646
    [No Abstract]   [Full Text] [Related]  

  • 10. [Blood circulation and ECG under the effect of propiramfumarate. Results of a double blind study].
    Kollert W; Hullmann R; Sommer J
    Arzneimittelforschung; 1974 Apr; 24(4):701-7. PubMed ID: 4599304
    [No Abstract]   [Full Text] [Related]  

  • 11. Tiapamil dose ranging study on exercise performance in patients with exercise induced angina and coronary artery disease.
    Maltz MB; O'Keefe JC; Butrous GS; Camm AJ
    Arq Bras Cardiol; 1984 Jun; 42(6):443-6. PubMed ID: 6393922
    [No Abstract]   [Full Text] [Related]  

  • 12. [Unexpected action of lidoflazine in atrial fibrillation. Preliminary report].
    Bortoluzzi DL; Rodrigues R
    Arq Bras Cardiol; 1971 Oct; 24(5):49-55. PubMed ID: 5139773
    [No Abstract]   [Full Text] [Related]  

  • 13. Acute effects of a single dose of phosphodiesterase type 5 inhibitor (sildenafil) on systemic arterial blood pressure during exercise and 24-hour ambulatory blood pressure monitoring in heart transplant recipients.
    Guimaraes GV; d'Avila VM; Pires P; Bacal F; Stolf N; Bocchi E
    Transplant Proc; 2007 Dec; 39(10):3142-9. PubMed ID: 18089340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical trial of the new coronary dilator hexobendine].
    Henke C; Dudik E; Steim H
    Arzneimittelforschung; 1968 Aug; 18(8):1103-7. PubMed ID: 4885101
    [No Abstract]   [Full Text] [Related]  

  • 15. The effects of sildenafil on heart rate variability in healthy subjects.
    Siepmann M; Rauh R; Dill O; Agelink MW; Mueck-Weymann M
    J Cardiovasc Pharmacol; 2007 Nov; 50(5):598-600. PubMed ID: 18030072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacology and clinical effects of lidoflazine].
    Janssen PA
    Actual Pharmacol (Paris); 1970; 23():135-61. PubMed ID: 4948983
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of lidoflazine in atrial muscle.
    Ilhan M; Kayaalp SO
    Arzneimittelforschung; 1973 May; 23(5):640-1. PubMed ID: 4740202
    [No Abstract]   [Full Text] [Related]  

  • 18. Sotalol in the treatment of angina pectoris. A double-blind cross-over study.
    Kentala E; Pyörälä K; Frick MH
    Ann Clin Res; 1974 Oct; 6(5):253-7. PubMed ID: 4614692
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term evaluation of lidoflazine in angina pectoris based on exercise tolerance.
    Piessens J; De Geest H
    Cardiology; 1972; 57(3):135-49. PubMed ID: 4557527
    [No Abstract]   [Full Text] [Related]  

  • 20. [Determination of effort tolerance in coronary patients after Intencordin and propranolol administration].
    Adamska-Dyniewska H; Goch JH
    Pol Tyg Lek; 1973 Oct; 28(43):1683-4. PubMed ID: 4587425
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.